Sekisui Jushi (4212) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
11 Mar, 2026Executive summary
Net sales and profits increased year-over-year, driven by steady performance in existing businesses, consolidation of RIKEN KOGYO Inc., and strong M&A contributions.
Operating profit rose 19.7% year-over-year, supported by sales expansion and finalization of provisional accounting procedures.
Comprehensive income surged 92.0% year-over-year to ¥4,144 million for the nine-month period.
Full-year earnings outlook remains unchanged despite a highly uncertain business environment in 4Q.
Completed repurchase of 1,000,000 shares of treasury stock on January 9, 2026.
Financial highlights
Net sales for 3Q cumulative period rose to ¥54,582 million, up 5.5% year-over-year.
Operating profit increased to ¥3,250 million, up 19.7% year-over-year.
Ordinary profit reached ¥3,700 million, up 20.1% year-over-year.
Net income attributable to owners of parent was ¥2,393 million, up 49.0% year-over-year.
EBITDA increased to ¥6,210 million, up 16.7% year-over-year.
Outlook and guidance
Full-year forecast for FYE March 2026 remains unchanged: net sales ¥79,000 million (+6.4%), operating profit ¥6,400 million (+27.7%), ordinary profit ¥6,700 million (+23.0%), net income ¥4,300 million (+21.3%), and basic EPS ¥143.50.
Return on equity (ROE) forecasted to rise from 3.7% to 4.5%.
Year-end dividend expected to increase by ¥1 to ¥36, with annual dividend up by ¥2 to ¥72.
Latest events from Sekisui Jushi
- Sales rose on M&A gains, but profits fell; 2H outlook and shareholder returns remain strong.4212
Q2 202511 Mar 2026 - Sales up 18.2% YoY, profit down on higher costs; profit growth and higher dividends expected.4212
Q4 202511 Mar 2026 - Sales up 19.5% YoY, but profits fell on higher costs; outlook and dividend growth maintained.4212
Q3 202511 Mar 2026 - Sales and profits increased, with strong outlook and share buyback supporting EPS growth.4212
Q1 202611 Mar 2026 - Profits and sales grew strongly, with higher dividends and continued share buybacks.4212
Q2 202611 Mar 2026 - Sales rose but profits fell on higher costs; full-year outlook remains positive.4212
Q1 202511 Mar 2026